Download PDF
Fortschr Neurol Psychiatr 2017; 85(10): 584-591
DOI: 10.1055/s-0043-118338
Übersicht
Georg Thieme Verlag KG Stuttgart · New York

Die Rolle des Eye Movement Desensitization and Reprocessing (EMDR) bei Substanzgebrauchsstörungen: Ein systematischer Überblick

The role of eye movement desensitization and reprocessing (EMDR) in substance use disorders: A systematic review
René Pilz
1   Medizinische Universität Graz, Universitätsklinik für Psychiatrie und Psychotherapeutische Medizin
2   Verein Grüner Kreis, Zentrum für Integrative Suchtforschung
,
Riccarda Hartleb
1   Medizinische Universität Graz, Universitätsklinik für Psychiatrie und Psychotherapeutische Medizin
,
Gabriela Konrad
2   Verein Grüner Kreis, Zentrum für Integrative Suchtforschung
,
Eva Reininghaus
1   Medizinische Universität Graz, Universitätsklinik für Psychiatrie und Psychotherapeutische Medizin
,
Human Friedrich Unterrainer
1   Medizinische Universität Graz, Universitätsklinik für Psychiatrie und Psychotherapeutische Medizin
2   Verein Grüner Kreis, Zentrum für Integrative Suchtforschung
› Author Affiliations
Further Information

Publication History

09/24/2016

08/11/2017

Publication Date:
10 October 2017 (online)

    Permissions and Reprints

Zusammenfassung

Das Eye Movement Desensitization and Reprocessing (EMDR) ist eine therapeutische Methode, deren Wirksamkeit in der Behandlung von traumatischen Erkrankungen gezeigt werden konnte. Seit der Annahme eines spezifischen Suchtgedächtnisses bildet EMDR auch für Substanzgebrauchsstörungen einen eigenen Anwendungsbereich. Die vorliegende Überblicksarbeit fasst den aktuellen Forschungsstand zu EMDR-Behandlungseffekten bei stoffgebundenen Abhängigkeitserkrankungen zusammen. Mithilfe der Datenbanken PubMed und PsychInfo wurde eine systematische Literaturrecherche durchgeführt, wobei vier relevante Studien identifiziert wurden. Bei der Behandlung mit EMDR zeigte sich eine Reduktion des Cravings, der Angst und der Depressionswerte, sowie eine Verbesserung der Emotionsregulierung und des Selbstwertgefühls. Erste Ergebnisse verweisen auf das hohe therapeutische Potential von EMDR für den Bereich der Substanzgebrauchsstörungen

Abstract

Eye Movement Desensitization and Reprocessing (EMDR) is a therapeutic method that has been shown to be especially effective in traumatic disorders. Since the concept of an addiction memory has become widely accepted, the use of EMDR also in substance use disorders (SUD) treatment might count as a separate field. This review summarizes the current state of research on treatment effects EMDR in SUD. The literature search included the databases of PubMed and PsychInfo; four studies met the inclusion criteria. EMDR was found to be related to a decreased amount of craving, fear and depression and to an improvement of emotion regulation and management and self-esteem. Initial findings indicate a high therapeutic potential of EMDR in SUD treatment.

Schlüsselwörter

Abhängigkeit - EMDR - Neuro-kognitive Interventionen - Substanzgebrauchsstörungen - Systematischer Überblick

Key words

Addiction - EMDR - neuro-cognitive interventions - substance use disorder - systematic review
 

  • Literatur

  • 1 American Psychiatric Association. Practice guidelines for the treatment patients with acute stress disorder and posttraumatic stress disorder. Arlington, VA: Author; 2004
    Google Scholar
  • 2 Lee CW, Taylor G, Drummond PD. The active ingredient in EMDR: Is it traditional exposure or dual focus of attention?. Clin. Psychol. Psychother. 2006; 13: 97-107
    CrossrefPubMedGoogle Scholar
  • 3 Sack M, Lempa W, Lamprecht F. Metaanalyse der Studien zur EMDR-Behandlung von Patienten mit posttraumatischen Belastungsstörungen – Der Einfluss der Studienqualität auf die Effektstärken -. PPmP – Psychother. · Psychosom. · Medizinische Psychol. [Internet]. 2001 51. 350-5 Available from: http: //www.thieme-connect.de/DOI/DOI?10.1055/s-2001-16898
    PubMedGoogle Scholar
  • 4 Shapiro F. Efficacy of the eye movement desensitization procedure in the treatment of traumatic memories. J. Trauma. Stress 1989; 2: 199-223
    CrossrefPubMedGoogle Scholar
  • 5 Hofmann A. EMDR in Therapie psychotraumatischer Belastungssymptome. Stuttgart: Thieme; 1999
    Google Scholar
  • 6 Antrobus JS, Antrobus JS, Singer JL. Eye movements accompanying daydreaming, visual imagery, and thought suppression. J. Abnorm. Soc. Psychol 69: 244-252
    PubMedGoogle Scholar
  • 7 Shapiro F. Eye movement desensitization: A new treatment for post-traumatic stress disorder. J. Behav. Ther. Exp. Psy- chiatry 1989; 20: 211-7
    PubMedGoogle Scholar
  • 8 Shapiro F. Alternative stimuli in the use of EMD(R). J. Behav. Ther. Exp. Psychiatry 1994; 25: 89
    CrossrefPubMedGoogle Scholar
  • 9 Shapiro F. Eye Movement Desensitization and Reprocessing: Basic principles, protocols, and procedures. New York: Guilford Press; 2001
    Google Scholar
  • 10 Shapiro F. EMDR 12 years after its introduction: Past and future research. J. Clin. Psychol 2002; 58: 1-22
    CrossrefPubMedGoogle Scholar
  • 11 Stickgold R, Hobson Ja, Fosse R. et al. Sleep, learning, and dreams: off-line memory reprocessing. Science 2001; 294: 1052-7
    CrossrefPubMedGoogle Scholar
  • 12 Stickgold R. EMDR: A putative neurobiological mechanism of action. J. Clin. Psychol 2002; 58: 61-75
    CrossrefPubMedGoogle Scholar
  • 13 Gunter RW, Bodner GE. How eye movements affect unpleasant memories: Support for a working-memory account. Behav. Res. Ther 2008; 46: 913-31
    CrossrefPubMedGoogle Scholar
  • 14 Shapiro F. EMDR Eye Movement Desensitization and Reprocessing – Grundlagen und Praxis, Handbuch zur Behandlung traumatisierter Menschen. Paderborn: Junfermann; 1998
    Google Scholar
  • 15 Schubbe O. Traumatherapie mit EMDR. Göttingen: Vandenhoeck & Ruprecht; 2015
    Google Scholar
  • 16 Galley N, Hofmann A. Eye Movement Desensitization and Reprocessing (EMDR) als Behandlungsmethode bei psycho-traumatischen Hyper- und Amnesien. In: Calabrese P. editor Gedächtnis und Gedächtnisstörungen. Klin. Aspekte aus Forsch. und Praxis. Lengerich: Pabst Science Publishers; 1999. p. 217-40
    Google Scholar
  • 17 Lee CW, Cuijpers P. A meta-analysis of the contribution of eye movements in processing emotional memories. J. Behav. Ther. Exp. Psychiatry 2013; 44
    PubMedGoogle Scholar
  • 18 Heber R, Kellner M, Yehuda R. Salivary cortisol levels and the cortisol response to dexamethasone before and after EMDR: A case report. J. Clin. Psychol 2002; 58: 1521-30
    CrossrefPubMedGoogle Scholar
  • 19 Lansing K, Amen DG, Hanks C. et al. High–Resolution Brain SPECT Imaging and Eye Movement Desensitization and Reprocessing in Police Officers With PTSD. J. Neuropsychiatry Clin. Neurosci 2005; 17: 526-32
    CrossrefPubMedGoogle Scholar
  • 20 Lamprecht F. Spuren im Körper, Erinnerung und EMDR. Praxis der Traumatherapie. Stuttgart: Klett-Cotta; 2000
    Google Scholar
  • 21 Hase M, Hofmann A. Risiken und Nebenwirkungen beim Einsatz der EMDR-Methode. PTT Persönlichkeitsstörungen Theor. und Prax 2005; 9: 16-21
    PubMedGoogle Scholar
  • 22 Tesarz J, Leisner S, Gerhardt A. et al. Effects of Eye Movement Desensitization and Reprocessing (EMDR) Treatment in Chronic Pain Patients: A Systematic Review. Pain Med 2014; 15: 247-63
    CrossrefPubMedGoogle Scholar
  • 23 de Roos C, Veenstra A, de Jongh A. et al. Treatment of chronic phantom limb pain using a trauma-focused psychological approach. Pain Res Manag 2010; 15: 65-71
    PubMedGoogle Scholar
  • 24 de Jongh A, ten Broeke E. Treatment of specific phobias with EMDR: Conceptualization and strategies for the selection of appropriate memories. J. EMDR Pract. Res 2007; 1: 46-56
    PubMedGoogle Scholar
  • 25 de Roos C, de Jongh A. EMDR Treatment of Children and Adolescents With a Choking Phobia. J. EMDR Pract. Res 2008; 2: 201-11
    PubMedGoogle Scholar
  • 26 Plassmann R, Seidel M. EMDR in der Gruppe bei Essstörungen. Das Ressourcenverankerungsprotokoll. Forum der Kinder- und Jugendpsychiatrie und Psychother 2003; 13: 33-45
    PubMedGoogle Scholar
  • 27 Plassmann R. Im eigenen Rhythmus. Gießen: Psychosozial-Verlag; 2008
    Google Scholar
  • 28 Shapiro F, Vogelmann-Sine S, Sine LF. Eye Movement Desensitization and Reprocessing: Treating Trauma and Substance Abuse. J. Psychoactive Drugs 1994; 26: 379-91
    CrossrefPubMedGoogle Scholar
  • 29 Vogelmann-Sine S. EMDR Chemical Dependency Treatment Manual. Honolulu, Hawaii: Author; 1998
    Google Scholar
  • 30 Popky AJ. DeTUR, an Urge Reduction Protocol für Addictions and Dysfunctional Behaviors. In: Shapiro R. editor EMDR Solut. New York, London: Norton; 2005
    Google Scholar
  • 31 Flik CE, de Roos C. Behandeling van fantoompijn met eye movement desensitisation and reprocessing (EMDR). Tijdschr. Psychiatr 2010; 52: 589-93
    PubMedGoogle Scholar
  • 32 Schneider J, Hofmann A, Rost C. et al. EMDR in the treatment of chronic phantom limb pain. Pain Med 2008; 9: 76-82
    CrossrefPubMedGoogle Scholar
  • 33 Hase M, Schallmayer S, Sack M. EMDR Reprocessing of the Addiction Memory: Pretreatment, Posttreatment, and 1-Month Follow-Up. J. EMDR Pract. Res 2008; 2: 170-9
    PubMedGoogle Scholar
  • 34 Littel M, Van Den Hout MA, Engelhard IM. Desensitizing addiction: Using eye movements to reduce the intensity of substance-related mental imagery and craving. Front. Psychiatry 2016; 7: 1-11
    PubMedGoogle Scholar
  • 35 Perez-Dandieu B, Tapia G. Treating Trauma in Addiction with EMDR: A Pilot Study. J. Psychoactive Drugs 2014; 46: 303-9
    CrossrefPubMedGoogle Scholar
  • 36 Meysami-Bonab S, Abolghasemi A, Sheikhian M. et al. The Effectiveness of Eye Movement Desensitization and Reprocessing Therapy on the Emotion Regulation and Emotion Recognition of Addicted Individuals. Zahedan J. Res. Med. Sci 2012; 14: 33-7
    PubMedGoogle Scholar
  • 37 Luber M. editor Eye Movement Desensitization and Reprocessing: EMDR Scripted Protocols and Summery sheets. New York: Springer Publishing Company; 2015
    Google Scholar
  • 38 Aldao A, Nolen-Hoeksema S, Schweizer S. Emotion-regulation strategies across psychopathology: A meta-analytic review. Clin. Psychol. Rev 2010; 30: 217-37
    CrossrefPubMedGoogle Scholar
  • 39 Trinidad DR, Unger JB, Chou CP. et al. The protective association of emotional intelligence with psychosocial smoking risk factors for adolescents. Pers. Individ. Dif 2004; 36: 945-54
    CrossrefPubMedGoogle Scholar
  • 40 Parker JDA, Taylor RN, Eastabrook JM. et al. Problem gambling in adolescence: Relationships with internet misuse, gaming abuse and emotional intelligence. Pers. Individ. Dif 2008; 45: 174-80
    CrossrefPubMedGoogle Scholar
  • 41 Verdejo-García A, Lawrence AJ, Clark L. Impulsivity as a vulnerability marker for substance-use disorders: Review of findings from high-risk research, problem gamblers and genetic association studies. Neurosci. Biobehav. Rev 2008; 32: 777-810
    CrossrefPubMedGoogle Scholar
  • 42 Loree AM, Lundahl LH, Ledgerwood DM. Impulsivity as a predictor of treatment outcome in substance use disorders: Review and synthesis. Drug Alcohol Rev 2015; 34: 119-34
    CrossrefPubMedGoogle Scholar
  • 43 Shapiro F, Hofmann A. Einführungsseminar in die EMDR-Methode—Manual Teil 1 von 2. Watsonville, CA, & Bergisch-Gladbach: 1994
    Google Scholar
  • 44 Feuerlein W, Ringer C, Kufner H. et al. The diagnosis of alcoholism—the Munich Alcoholism Test (MALT). Int. J. Rehabil. Res 1979; 2: 533-534
    CrossrefPubMedGoogle Scholar
  • 45 Magraf J. Diagnostisches Kurz-Inventar bei psychischen Störungen. Berlin: Springer; 1994
    Google Scholar
  • 46 Eid J, Thayer JF, Johnsen BH. Measuring post-traumatic stress: a psychometric evaluation of symptom- and coping questionnaires based on a Norwegian sample. Scand. J. Psychol 1999; 40: 101-8
    PubMedGoogle Scholar
  • 47 Bernstein EM, Putnam FW. Development, Reliability, and Validity of a Dissociation Scale. J. Nerv. Ment. Dis 1986; 174: 727-35
    CrossrefPubMedGoogle Scholar
  • 48 Nijenhuis ERS, Spinhoven P, van Dyck R. et al. The development of the somatoform dissociation questionnaire (SDQ-5) as a screening instrument for dissociative disorders. Acta Psychiatr. Scand 1997; 96: 311-8
    CrossrefPubMedGoogle Scholar
  • 49 Beck AT, Ward CH, Mendelson M. et al. An Inventory for Measuring Depression. Arch. Gen. Psychiatry 1961; 4: 561
    CrossrefPubMedGoogle Scholar
  • 50 Spielberger CD, Gorsuch RL, Lushene R. Manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press; 1970
    Google Scholar
  • 51 Mann K, Ackermann K. Die OCDS-G: Psychometrische Kennwerte der deutschen Version der Obsessive Compulsive Drinking Scale. Sucht 2015; 46: 90-100
    PubMedGoogle Scholar
  • 52 Garnefski N, Kraaij V, Spinhoven P. Negative life events, cognitive emotion regulation and emotional problems. Pers. Individ. Dif 2001; 30: 1311-27
    CrossrefPubMedGoogle Scholar
  • 53 Ekman P, Friesen W. Pictures of facial affect. Palo Alto, CA: Consulting Psychologists Press; 1976
    Google Scholar
  • 54 Fagerstrom K-O, Schneider NG. Measuring nicotine dependence: A review of the Fagerstrom Tolerance Questionnaire. J. Behav. Med 1989; 12: 159-82
    CrossrefPubMedGoogle Scholar
  • 55 Cox LS, Tiffany ST, Christen AG. Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings. Nicotine Tob. Res 2001; 3: 7-16
    CrossrefPubMedGoogle Scholar
  • 56 Cornil L. Formation Initiale à la Thérapie EMDR. Institut Français D’EMDR, Intégrativa; 2011
    Google Scholar
  • 57 Weathers F, Litz B, Herman D. et al. The PTSD Checklist (PCL): Reliability, Validity, and Diagnostic Utility. Paper presented at the Annual Convention of the International Society for Traumatic Stress Studies, October 1993; San Antonio, TX: 1993
    Google Scholar
  • 58 McLellan AT, Luborsky L, O’Brien CP. et al. An improved diagnostic instrument for substance abuse patients, The Addiction Severity Index. J. Nerv. Ment. Dis 1980; 168: 26-33
    CrossrefPubMedGoogle Scholar
  • 59 Coopersmith S. Self-Esteem Inventories. Palo Alto, CA: Consulting Psychologists Press; 1981
    Google Scholar
  • 60 Bagby RM, Parker JDA, Taylor GJ. The twenty-item Toronto Alexithymia scale—I. Item selection and cross-validation of the factor structure. J. Psychosom. Res 1994; 38: 23-32
    CrossrefPubMedGoogle Scholar